Topotecan/vincristine - LipoCureAlternative Names: LC 300; LipoViTo
Latest Information Update: 18 Apr 2016
At a glance
- Originator LipoCure
- Class Camptothecins; Small molecules; Vinca alkaloids
- Mechanism of Action DNA topoisomerase I inhibitors; Tubulin polymerisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 18 Apr 2016 Preclinical trials in Solid tumours in Israel (unspecified route)